Safety Study of Rituximab (Rituxan®) in Chronic Urticaria
Clinical trial NCT00216762 · TERMINATED
Trial details
- NCT number
- NCT00216762
- Sponsor
- Johns Hopkins University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2007-05-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.